<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04400500</url>
  </required_header>
  <id_info>
    <org_study_id>01-02/20</org_study_id>
    <nct_id>NCT04400500</nct_id>
  </id_info>
  <brief_title>Differential Diagnosis and Risk Stratification in Patients With Suspected NSTEACS</brief_title>
  <official_title>Approaches to Differential Diagnosis and Risk Stratification in Patients Hospitalized With Suspected Acute Coronary Syndrome Without Persistent ST-segment Elevation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Research Center for Preventive Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Research Center for Preventive Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate possibilities of rapid differential diagnosis and risk stratification in patients
      urgently admitted to the CCU with a suspected acute coronary syndrome without persistent
      ST-segment elevation (NSTEACS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single centre prospective non-randomised non-comparative study of patients delivered by
      ambulance and admitted to the CCU with suspected NSTEACS.

      Aims of this study are:

        1. To characterize the contingent of patients admitted to the CCU with suspected NSTEACS.

        2. To evaluate possibilities of fast differential diagnosis and risk stratification in
           patients admitted to the CCU with suspected NSTEACS using clinical data, ECG, biomarker
           levels (hsTn, NT-proBNP, hsCPR, cardiac FABP) as well as HEART, ADAPT, EDACS, T-MACS,
           GRACE, ACTION and TIMI scores.

        3. To evaluate the correlation between clinical data, ECG, biomarker levels (hsTn,
           NT-proBNP, hsCPR, cardiac FABP) as well as HEART, ADAPT, EDACS, T-MACS, GRACE, ACTION
           and TIMI scores with presence and severity of coronary atherosclerosis in patients
           admitted to the CCU (intensive care unit) with suspected NSTEACS.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical outcomes</measure>
    <time_frame>6 monts</time_frame>
    <description>Composite of death, (re) infarction, stroke or re-hospitalization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Final diagnosis</measure>
    <time_frame>Up to 1 monts</time_frame>
    <description>Final diagnosis - the main reason for urgent hospitalization - according to hospital case history</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>6 months.</time_frame>
    <description>Death upon discharge and up to 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>(re) infarction</measure>
    <time_frame>Up to 1 monts</time_frame>
    <description>(re) infarction upon discharge and up to 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>6 months.</time_frame>
    <description>Stroke upon discharge and up to 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-hospitalization</measure>
    <time_frame>6 months.</time_frame>
    <description>Recurrent hospital admissions after discharge form the index hospitalization</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Urgent revascularisation</measure>
    <time_frame>Up to 1 monts</time_frame>
    <description>Revascularisation performed due to sudden clinical deterioration</description>
  </other_outcome>
  <other_outcome>
    <measure>Other adverse events</measure>
    <time_frame>6 months.</time_frame>
    <description>All adverse events/complications not included in clinical outcomes end points.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Non ST Segment Elevation Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Suspected NSTEACS</arm_group_label>
    <description>Patients urgently admitted to the CCU with suspected NSTEACS</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Approaches to differential diagnosis and risk stratification</intervention_name>
    <description>Detailed analysis of clinical course, ECG, biomarkers (hsTn I, CK-MB mass, myoglobin, NT-proBNP, hsCPR, cardiac FABP on admission and after 3 hours; hsTn I, CK-MB mass and myoglobin after 6 hours if needed) as well as HEART, ADAPT, EDACS, T-MACS, GRACE, ACTION and TIMI scores.</description>
    <arm_group_label>Suspected NSTEACS</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      hsTn, NT-proBNP, hsCPR, cardiac FABP
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients delivered by ambulance and admitted to the CCU with suspected diagnosis &quot;acute
        coronary syndrome (ACS)&quot;.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Delivered by ambulance to the CCU with suspected diagnosis &quot;acute coronary syndrome
             (ACS)&quot;.

          2. Signed informed consent.

        Exclusion Criteria:

          1. ACS with persistent ST-segment elevation.

          2. Moribund; extremely severe condition on admission with a potentially unfavourable
             prognosis (cardiogenic shock, coma, cardiac arrest, an urgent need for mechanical
             ventilation).

          3. Overt non-cardiac cause of clinical manifestations at the time of admission (bleeding,
             pulmonary embolism, aortic dissection, stroke).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Igor S Yavelov, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Medical Research Center for Therapy and Preventive Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vitaliy A Moshanov, RA</last_name>
    <phone>79175694724</phone>
    <email>moshanov.vitalii@mail.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Igor S Yavelov, PhD</last_name>
    <phone>79166059047</phone>
    <email>yavelov@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Eramishantsev Hospital</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 23, 2020</study_first_submitted>
  <study_first_submitted_qc>May 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2020</study_first_posted>
  <last_update_submitted>June 6, 2020</last_update_submitted>
  <last_update_submitted_qc>June 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non ST segment Elevation Acute Coronary Syndrome</keyword>
  <keyword>Diagnosis</keyword>
  <keyword>Prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

